Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HVT + ND vaccine
- Development stage
- Preclinical
- Lead developer
- MEVAC
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies, Vaccines & Immunotherapeutics
- Administration
- In-ovo, Subcutaneous
01
Overview
HVT + ND vaccine is a combined veterinary vaccine developed by Middle East for Vaccines (MEVAC) for the protection of poultry against Marek's disease and Newcastle disease. The vaccine typically utilizes a recombinant Herpesvirus of Turkeys (HVT) as a viral vector to express protective antigens, such as the fusion (F) protein, from the Newcastle Disease Virus (NDV). This viral vector platform allows the vaccine to be administered early in the production cycle, often via in-ovo injection or to day-old chicks at the hatchery. It is designed to induce long-lasting immunity while overcoming the interference of maternally derived antibodies, which is a common challenge in young poultry.
- Brand names
- MEVAC HVT+ND
- Other names
- Herpesvirus of Turkeys + Newcastle Disease VaccineHVT + ND VaccineHerpesvirus Turkey + Newcastle Disease (Poultry) Vaccine
Beyond the preview
Go deeper on HVT + ND vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HVT + ND vaccine.